1. Diamyd Medical AB: Chairman increases holdings in Diamyd
(News/Press releases)

... +46 8 661 00 26. E-mail: press@diamyd.com About Diamyd Medical Diamyd Medical is a Swedish diabetes company. The company was formerly called Diamyd Therapeutics and was spun off from Mertiva AB (formerly ...

2. ChronTech Pharma AB: Report from the extra general meeting
(News/Press releases)

... ChronTech ChronTech develops the therapeutic DNA vaccines ChronVac-C® and ChronVac-B drugs against chronic hepatitis C virus and hepatitis B virus infections, i.e. chronic infections with jaundice ...

3. Diamyd Medical AB: New Diamyd Medical listed on NASDAQ OMX First North on May 20, 2013
(News/Press releases)

... therapeutics or by providing treatment before onset of the disease. Combination therapies have, for example, played a decisive role in the advances made in cancer treatment in recent years. Many leading ...

4. Getinge Group: Getinge issues five year bonds
(News/Press releases)

... billion was issued as a Fixed Rate Note with a coupon rate at 3.5%. The proceeds from the loan will be used to refinance the Therapeutic Support Systems (TSS) acquisition debt. The arranging banks were ...

5. ChronTech Pharma AB: Report from the extra general meeting
(News/Press releases)

... the therapeutic DNA vaccines ChronVac-C® and ChronVac-B drugs against chronic hepatitis C virus and hepatitis B virus infections, i.e. chronic infections with jaundice causing viruses which can lead ...

6. Aerocrine: Interim report January - March 2013
(News/Press releases)

...  · Georgia Medicaid became the 37th state to reimburse FeNO testing in the U.S. · Health Canada's Therapeutic Products Directorate has authorized Aerocrine's latest NIOX MINO® ...

7. ChronTech Pharma AB: INTERIM REPORT JANUARY-MARCH 2013 CHRONTECH PHARMA
(News/Press releases)

... resolves according to the proposal, hold the 20-percentage ownership in Opsonic Therapeutics Inc. as well as the entire holding in the needle technology IVIN. · The Board continues to work to ...

8. Moberg Pharma: MOBERG DERMA BECOMES MOBERG PHARMA
(News/Press releases)

... cover other areas than skin conditions and as we continue to build a different kind of pharmaceutical company, we expect to operate in additional therapeutic areas," said Peter Wolpert, CEO of Moberg ...

9. ChronTech Pharma AB: Notice of Extra General Meeting
(News/Press releases)

... Research, ChronTech Pharma AB Mobile phone: +46 709 28 05 28 E-mail: anders.vahlne@chrontech.se About ChronTech ChronTech develops the therapeutic DNA vaccines ChronVac-C® and ChronVac-B drugs against ...

10. ChronTech Pharma AB: ChronTech receives extended offer from a group of shareholder
(News/Press releases)

...  About ChronTech ChronTech develops the therapeutic DNA vaccines ChronVac-C® and ChronVac-B drugs against chronic hepatitis C virus and hepatitis B virus infections, i.e. chronic infections with jaundice ...

11. Vitrolife AB (publ): Report from Annual General Meeting of Vitrolife AB (publ)
(News/Press releases)

... products for the treatment of human infertility. Work is also carried out to enable the use and handling of stem cells for therapeutic purposes Vitrolife (http://www.vitrolife.com/en/Corporate/) has ...

12. ChronTech Pharma AB: Report from the extra general meeting
(News/Press releases)

... needle IVIN, the Company will keep also the 20-percentage ownership in Opsonic Therapeutics Inc. Before the transactions the Company has 181,137,022 outstanding shares and those shares that will be redeemed ...

13. Vitrolife AB (publ): Interim report January-March 2013: High growth and increased income
(News/Press releases)

... products for the treatment of human infertility. Work is also carried out to enable the use and handling of stem cells for therapeutic purposes Vitrolife (http://www.vitrolife.com/en/Corporate/) has ...

14. Aerocrine: Aerocrine's NIOX MINO® device for measuring FeNO receives approval by Health Canada
(News/Press releases)

SOLNA, Sweden - 16 April, 2013 - Aerocrine AB (OMX Nordic Exchange: AERO) announces that Health Canada's Therapeutic Products Directorate has authorized Aerocrine's latest NIOX MINO® for ...

15. Karo Bio: KARO BIO PUBLISHES ANNUAL REPORT
(News/Press releases)

... developing novel, more effective and safer pharmaceuticals. The company runs drug development projects mainly within the therapeutic areas neuropsychiatry, inflammation, autoimmune diseases and cancer. ...

16. RaySearch Laboratories: RaySearch licenses technology from GSI
(News/Press releases)

... refined the so called Local Effect Model (LEM) for calculating the relative biological effectiveness during irradiation with therapeutic carbon ion beams. In the LEM model the survival of cells irradiated ...

17. Elekta: Swedish Clinic Boosts Speed and Precision of Radiotherapy for Cancer Patients with Elekta Beam Shaping Technology
(News/Press releases)

... patients using radiotherapy systems equipped with Elekta's innovative Agility? 160-leaf multileaf collimator (MLC). It will enable clinicians there to rapidly and accurately tailor therapeutic radiation ...

18. Vitrolife AB (publ): Conference call interim report
(News/Press releases)

... also carried out to enable the use and handling of stem cells for therapeutic purposes Vitrolife (http://www.vitrolife.com/en/Corporate/) has approximately 230 employees and the company's products ...

19. Elekta: U.K. Clinic Anticipating New Era of Radiotherapy Speed and Precision with Elekta's New Versa HD System
(News/Press releases)

... combination of speed and accuracy, Elekta's new Versa HD? system will help clinicians at The Christie NHS Foundation Trust (Withington, Manchester) maximize the precision of therapeutic beams on the ...

20. ChronTech Pharma AB: Notice of EGM
(News/Press releases)

...  Anders Vahlne, CEO and Head of Research, ChronTech Pharma AB Mobile phone: +46 709 28 05 28, E-mail: anders.vahlne@ki.se About ChronTech ChronTech develops the therapeutic DNA vaccines ChronVac-C® ...